Paroxetine Tablet, Film Coated
Product Images NDC 60429-736

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 60429-736). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60429 734 30lb Paroxetine HCl 10 mg Tabs 2

60429 734 30lb   Paroxetine HCl 10 mg Tabs 2
This is a description of a medication produced by GSMS Incorporated. The medication is in tablet form with each tablet containing 10mg of paroxetine hydrochloride. The medication should be stored at a temperature of 15°C to 30°C, and it is advisable to dispense the medication with a safety closure. The pharmacist is also directed to provide the medication guide separately to each patient. The medication should be kept away from the reach of children and dispensed in a container that is tight and light-resistant. The manufacturer of the medication is Agotex Ine, while GSMS Incorporated packaged the medication in Camarillo, California.*
FDA Label Image

60429 735 30lb Paroxetine HCl 20mg Tabs

60429 735 30lb   Paroxetine HCl 20mg Tabs
This is a package insert from GSMS Incorporated for their Paroxetine Tablets USP, which come in a bottle containing 30 tablets, each with 20mg of paroxetine hydrochloride. The tablets should be stored at controlled room temperature, and out of the reach of children. Pharmacists are advised to consult the medication guide for dosage information and to dispense the medication in appropriately sealed containers. The tablets are manufactured by Apotex inc. in Toronto, Canada and packaged by GSMS, Inc. in Camarlio, GA.*
FDA Label Image

60429 736 30lb Paroxetine HCl 30 mg Tabs

60429 736 30lb   Paroxetine HCl 30 mg Tabs
NDC 60429-736-30 is a package of Paroxetine tablets, USP containing 30 tablets of 30mg each. It is recommended to check the package insert for dosage information. The tablets should be stored between 20° to 25°C (89" to 77°F) with allowable excursions to 16* to 30°C (59" o 86°F) [See USP Controllad Room Temperature]. The medication must be dispensed using safety closures and be kept out of reach of children. The tablets should be dispensed in a tight, light-resistant container. The manufacturer is Apotex Inc., located in Toronto, Ontario, Canada, and the product is packaged by GSMS, Incorporated in Camarillo, CA 83012 USA.*
FDA Label Image

60429 737 30lb Paroxetine HCl 40 mg Tabs

60429 737 30lb   Paroxetine HCl 40 mg Tabs
This is a medication containing Paroxetine, packaged as 30 tablets each with a dosage of 40mg. It is important to refer to the package insert for dosage information. The tablets should be stored at room temperature between 20° to 25°C. Each tablet contains Paroxetine hydrochloride equivalent to 40mg of Paroxetine. Safety closures should be used when dispensing the product and it must be kept out of reach from children. The medication should be dispensed in a tight, light-resistant container. It is manufactured by Apotex Inc. in Toronto, Ontario, Canada and packaged by GSMS, Incorporated located in Camarillo, CA in the USA.*
FDA Label Image

Figure1

Figure1
This text provides a list of interacting drugs, along with their respective dosages. It also mentions fold change and 80% CI, and indicates a change relative to the reference of 10.0. However, without additional context or information, it is not clear what this data pertains to or how it may be useful.*
FDA Label Image

Figure2

FDA Label Image

Figure3

Figure3
This is a population description containing information on renal and hepatic impairment, age, and gender. For renal impairment, the levels are categorized as mild, moderate, or severe. It suggests specific dosing for individuals over 65 years old. The gender breakdown only includes males. The rest of the text seems to be PK fold change and 90% confidence limits regarding various measurements. No further context is available to determine the relevance or significance of these measurements.*
FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.